Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Battle of the Bulge - A randomised study comparing the effect of three dietary approaches on cardiovascular risk in subject with the metabolic syndrome
ISRCTN ISRCTN05118860
ClinicalTrials.gov identifier
Public title Battle of the Bulge - A randomised study comparing the effect of three dietary approaches on cardiovascular risk in subject with the metabolic syndrome
Scientific title
Acronym N/A
Serial number at source N0212177254
Study hypothesis To compare the effectiveness of three dietary regimes in improving cardiovascular risk in subjects with the metabolic syndrome.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Nutritional, Metabolic, Endocrine: Metabolic syndrome
Participants - inclusion criteria Males or non-pregnant females fulfilling the criteria for the metabolic syndrome - these include the presence of 3 or more of the following:
1. Abdominal obesity (waist circumference >102cm in men and > 88cm in women
2. Triglyceride level >150mg/Dl
3. HDL cholesterol <40mg/dL for men, <50mg/dL for women
4. Blood pressure >130mm systolic or 85mm diastolic
5. Fasting plasma glucose >6.1mmol/dL
Participants - exclusion criteria 1. Recent cardiovascular event ie stroke, myocardial infarction, or pulmonary embolism within past 4 months
2. Ongoing chronic inflammatory condition: vasculitis, ulcers, inflammatory bowel disease, malignant disorder
3. Renal impairment (creatinine >135)
4. Hepatic impairment (ALT or AST> 4x upper limit of normal)
5. On statin therapy for dyslipaemia
6. Poorly controlled diabetes. Type 2 diabetes on insulin therapy. Type 2 diabetes on thiazolidinione.
7. Untreated thyroid disorders - should be stable on thyroid medication for at least 3 months.
8. Known Cushings syndrome
9. On an anorectic agent ie Orlistat, sibutramine - can be given a 4 week washout period
10. Food allergies/intolerance
11. Vegetarian
Anticipated start date 01/03/2004
Anticipated end date 01/05/2007
Status of trial Completed
Patient information material
Target number of participants 120 - recruitment is completed as of July 2008.
Interventions Comparison of three dietary approaches.
Primary outcome measure(s) Improving the cardiovascular risks associated with the Metabolic Syndrome has long-term beneficial effects on health and quality of life. Management through dietary lifestyle changes is possibly the healthier option with less chances of side effects or interactions as would be expected through drugs.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Royal United Hospital Bath NHS Trust (UK)
Diabetes Research Fund
Trial website
Publications
Contact name Dr  Rasha  Mukhtar
  Address Wolfson Centre
Royal United Hospital
  City/town Bath
  Zip/Postcode BA1 3NG
  Country United Kingdom
  Tel +44 01225 428331
  Fax +44
  Email mpxrm@bath.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 06/10/2011
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central